Literature DB >> 19830587

Cognitive and social profiles in two patients with cobalamin C disease.

M H Beauchamp1, V Anderson, A Boneh.   

Abstract

Cobalamin C (cblC) disease, an inborn error of vitamin B(12) metabolism, results in neurometabolic, neurochemical and neuroanatomical changes. Little is known of the long-term effects of the disorder on cognition and behaviour in children. Here, the complete neuropsychological profiles of two 12-year-old girls with cblC disease are presented. The two girls were tested longitudinally with standardized neuropsychological tests including intellectual ability, attention and memory, as well as executive, adaptive and behavioural function. The results indicate the presence of intellectual dysfunction, attention problems, and concerns with behavioural aspects of executive function. Both patients demonstrated a pattern of decreasing intellectual function over time, which may reflect a growing developmental gap in comparison with their same age peers. These impairments are in contrast to the relatively spared verbal expression and comprehension abilities, as well as strengths in sociability. The findings highlight a pattern of neuropsychological strengths and weaknesses that may distinguish cblC disease from other inborn errors of metabolism. Overt sociability such as observed in these two patients may actually mask underlying cognitive deficits because the patients appear to function at a more advanced level than that reflected by quantitative assessment of intellectual and cognitive functioning. This is of clinical and functional importance and suggests that accurate determination of cognitive, adaptive and social abilities necessitates an in-depth and broad evaluation. The presence of significant intellectual and cognitive deficits also underscores the need to document and monitor cognitive development in children with cblC disease and to consider remediative and adaptive learning strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19830587     DOI: 10.1007/s10545-009-1284-8

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  22 in total

1.  The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population.

Authors:  K Nilsson; L Gustafson; B Hultberg
Journal:  Clin Chem       Date:  2000-05       Impact factor: 8.327

2.  Cobalamin (Cbl) C/D deficiency: clinical, neurophysiological and neuroradiologic findings in 14 cases.

Authors:  R Biancheri; R Cerone; M C Schiaffino; U Caruso; E Veneselli; M V Perrone; A Rossi; R Gatti
Journal:  Neuropediatrics       Date:  2001-02       Impact factor: 1.947

3.  Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings.

Authors:  A Rossi; R Cerone; R Biancheri; R Gatti; M C Schiaffino; C Fonda; E Zammarchi; P Tortori-Donati
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

Review 4.  High cognitive outcome in an adolescent with mut- methylmalonic acidemia.

Authors:  L Varvogli; G M Repetto; S E Waisbren; H L Levy
Journal:  Am J Med Genet       Date:  2000-04-03

5.  Children's attentional skills 5 years post-TBI.

Authors:  Cathy Catroppa; Vicki A Anderson; Sue A Morse; Flora Haritou; Jeffrey V Rosenfeld
Journal:  J Pediatr Psychol       Date:  2006-07-13

6.  Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline.

Authors:  Christine C Tangney; Yuxiao Tang; Denis A Evans; Martha Clare Morris
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

7.  Neurological outcome of methylmalonic acidaemia.

Authors:  P Nicolaides; J Leonard; R Surtees
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

8.  Homocysteine: a marker for cognitive performance? A longitudinal follow-up study.

Authors:  C E Teunissen; A Henk J Blom; M P J Van Boxtel; H Bosma; C de Bruijn; J Jolles; B A Wauters; H W M Steinbusch; J de Vente
Journal:  J Nutr Health Aging       Date:  2003       Impact factor: 4.075

9.  "Everybody in the world is my friend" hypersociability in young children with Williams syndrome.

Authors:  Teresa F Doyle; Ursula Bellugi; Julie R Korenberg; John Graham
Journal:  Am J Med Genet A       Date:  2004-01-30       Impact factor: 2.802

10.  Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?

Authors:  Peter J Anderson; Stephen J Wood; Dorothy E Francis; Lee Coleman; Vicki Anderson; Avihu Boneh
Journal:  Dev Neuropsychol       Date:  2007       Impact factor: 2.253

View more
  6 in total

Review 1.  Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.

Authors:  Nuria Carrillo-Carrasco; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

2.  Clinical presentation and outcome in a series of 88 patients with the cblC defect.

Authors:  Sabine Fischer; Martina Huemer; Matthias Baumgartner; Federica Deodato; Diana Ballhausen; Avihu Boneh; Alberto B Burlina; Roberto Cerone; Paula Garcia; Gülden Gökçay; Stephanie Grünewald; Johannes Häberle; Jaak Jaeken; David Ketteridge; Martin Lindner; Hanna Mandel; Diego Martinelli; Esmeralda G Martins; Karl O Schwab; Sarah C Gruenert; Bernd C Schwahn; László Sztriha; Maren Tomaske; Friedrich Trefz; Laura Vilarinho; David S Rosenblatt; Brian Fowler; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2014-03-06       Impact factor: 4.982

3.  A Highly Diverse Portrait: Heterogeneity of Neuropsychological Profiles in cblC Defect.

Authors:  Jenny Bellerose; Mathilde Neugnot-Cerioli; Karine Bédard; Catherine Brunel-Guitton; Grant A Mitchell; Luis H Ospina; Miriam H Beauchamp
Journal:  JIMD Rep       Date:  2015-11-26

Review 4.  Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.

Authors:  Martina Huemer; Daria Diodato; Bernd Schwahn; Manuel Schiff; Anabela Bandeira; Jean-Francois Benoist; Alberto Burlina; Roberto Cerone; Maria L Couce; Angeles Garcia-Cazorla; Giancarlo la Marca; Elisabetta Pasquini; Laura Vilarinho; James D Weisfeld-Adams; Viktor Kožich; Henk Blom; Matthias R Baumgartner; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2016-11-30       Impact factor: 4.982

5.  Neurocognitive assessments and long-term outcome in an adult with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency.

Authors:  Karolina M Stepien; Philomena McCarthy; Eileen P Treacy; James J O'Byrne; Gregory M Pastores
Journal:  Mol Genet Metab Rep       Date:  2018-06-22

Review 6.  Neurodevelopmental and neuropsychiatric disorders in cobalamin C disease: a case report and review of the literature.

Authors:  Minh G Nguyen; Lauren Tronick; Faraz Modirian; Rebecca Mardach; Aaron D Besterman
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.